CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Gilead Sciences - GILD CFD

77.51
0.49%
0.29
Rendah: 76.49
Tinggi: 77.61
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 00:00

Mon - Thu: 08:10 - 00:00

Fri: 08:10 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.29
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Gilead Sciences Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 77.23
Open* 76.84
1-Year Change* 29.91%
Day's Range* 76.49 - 77.61
52 wk Range 57.17-89.74
Average Volume (10 days) 6.95M
Average Volume (3 months) 127.72M
Market Cap 96.41B
P/E Ratio 21.25
Shares Outstanding 1.25B
Revenue 27.28B
EPS 3.64
Dividend (Yield %) 3.88048
Beta 0.40
Next Earnings Date Apr 26, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 17, 2023 77.23 -2.28 -2.87% 79.51 79.78 76.46
Mar 16, 2023 78.98 0.19 0.24% 78.79 79.88 77.74
Mar 15, 2023 78.98 -0.65 -0.82% 79.63 79.82 78.03
Mar 14, 2023 78.62 -0.12 -0.15% 78.74 79.83 78.24
Mar 13, 2023 79.28 -0.26 -0.33% 79.54 81.19 76.94
Mar 10, 2023 79.00 0.48 0.61% 78.52 80.24 77.61
Mar 9, 2023 78.90 -0.83 -1.04% 79.73 80.58 78.22
Mar 8, 2023 79.73 -0.36 -0.45% 80.09 80.68 79.48
Mar 7, 2023 79.79 -0.94 -1.16% 80.73 81.23 79.79
Mar 6, 2023 81.04 0.27 0.33% 80.77 81.25 80.35
Mar 3, 2023 80.57 1.14 1.44% 79.43 81.09 79.03
Mar 2, 2023 79.43 -0.05 -0.06% 79.48 79.83 78.44
Mar 1, 2023 79.31 -0.98 -1.22% 80.29 80.58 78.93
Feb 28, 2023 79.96 -0.55 -0.68% 80.51 80.92 79.28
Feb 27, 2023 80.53 0.05 0.06% 80.48 81.24 79.61
Feb 24, 2023 80.59 -1.69 -2.05% 82.28 82.49 80.13
Feb 23, 2023 82.19 -0.74 -0.89% 82.93 83.77 82.10
Feb 22, 2023 82.93 -1.75 -2.07% 84.68 84.83 82.93
Feb 21, 2023 84.68 0.56 0.67% 84.12 85.41 83.75
Feb 17, 2023 84.35 1.17 1.41% 83.18 85.18 81.65

Gilead Sciences Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 30390 26107 22127 22449 24689 27305
Revenue 30390 26107 22127 22449 24689 27305
Cost of Revenue, Total 4261 4371 4853 4675 4572 6601
Gross Profit 26129 21736 17274 17774 20117 20704
Total Operating Expense 12757 11983 13927 18162 20618 17387
Selling/General/Admin. Expenses, Total 3398 3830 4056 4381 5151 5246
Research & Development 4266 3512 4846 8934 10895 5540
Unusual Expense (Income) 832 270 172 172
Operating Income 17633 14124 8200 4287 4071 9918
Interest Income (Expense), Net Non-Operating -790 -1190 -964 227 -2684 -1611
Other, Net 254 595 563 646 282 -29
Net Income Before Taxes 17097 13529 7799 5160 1669 8278
Net Income After Taxes 13488 10136 5464 5364 89 6201
Minority Interest 13 -16 -5 22 34 24
Net Income Before Extra. Items 13501 10120 5459 5386 123 6225
Net Income 13501 4628 5455 5386 123 6225
Income Available to Common Excl. Extra. Items 13501 10120 5459 5386 123 6225
Income Available to Common Incl. Extra. Items 13501 4628 5455 5386 123 6225
Dilution Adjustment 0
Diluted Net Income 13501 4628 5455 5386 123 6225
Diluted Weighted Average Shares 1358 1319 1308 1277 1263 1262
Diluted EPS Excluding Extraordinary Items 9.94183 7.67248 4.17355 4.2177 0.09739 4.93265
Dividends per Share - Common Stock Primary Issue 1.84 2.08 2.28 2.52 2.72 2.84
Diluted Normalized EPS 10.4252 7.82584 4.26568 4.30525 0.09739 4.93265
Total Extraordinary Items -5492 -4
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 6423 6217 7421 7244 6590
Revenue 6423 6217 7421 7244 6590
Cost of Revenue, Total 1361 1390 1223 2627 1424
Gross Profit 5062 4827 6198 4617 5166
Total Operating Expense 3533 3971 3579 6304 6393
Selling/General/Admin. Expenses, Total 1044 1351 1190 1650 1083
Research & Development 1117 1230 1166 2027 1186
Unusual Expense (Income) 11 2700
Operating Income 2890 2246 3842 940 197
Interest Income (Expense), Net Non-Operating -608 -430 -392 -181 -334
Other, Net -18 1 -12 -15
Net Income Before Taxes 2264 1817 3438 759 -152
Net Income After Taxes 1722 1517 2586 376 12
Minority Interest 7 5 6 6 7
Net Income Before Extra. Items 1729 1522 2592 382 19
Net Income 1729 1522 2592 382 19
Income Available to Common Excl. Extra. Items 1729 1522 2592 382 19
Income Available to Common Incl. Extra. Items 1729 1522 2592 382 19
Diluted Net Income 1729 1522 2592 382 19
Diluted Weighted Average Shares 1262 1260 1262 1262 1262
Diluted EPS Excluding Extraordinary Items 1.37005 1.20794 2.05388 0.30269 0.01506
Dividends per Share - Common Stock Primary Issue 0.71 0.71 0.71 0.71 0.73
Diluted Normalized EPS 1.37668 1.20794 2.05388 0.30269 1.40571
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 19588 31823 35836 30296 15996 14772
Cash and Short Term Investments 11895 25510 30089 24352 7408 6520
Cash & Equivalents 8229 7588 17940 11631 5997 5338
Short Term Investments 3666 17922 12149 12721 1411 1182
Total Receivables, Net 4514 3851 3327 3582 4892 4493
Accounts Receivable - Trade, Net 4514 3851 3327 3582 4892 4493
Total Inventory 1587 801 814 922 1683 1618
Prepaid Expenses 1592 1649 1533 1403 2013 2141
Total Assets 56977 70283 63675 61627 68407 67952
Property/Plant/Equipment, Total - Net 2865 3295 4006 5170 5613 5663
Goodwill, Net 1172 4159 4117 4117 8108 8332
Intangibles, Net 8971 17100 15738 13786 33126 33455
Long Term Investments 20495 11194 1423 1488 502 1309
Other Long Term Assets, Total 3886 2712 2555 6770 5062 4421
Total Current Liabilities 9218 11635 10605 9759 11397 11610
Accounts Payable 1206 814 790 713 844 705
Accrued Expenses 7775 7271 6876 6254 7198 7600
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 2747 2748 2499 2757 1516
Other Current Liabilities, Total 237 803 191 293 598 1789
Total Liabilities 38090 49841 42288 39102 50205 46883
Total Long Term Debt 26346 30795 24574 22094 28645 25179
Long Term Debt 26346 30795 24574 22094 28645 25179
Minority Interest 476 59 147 125 19 -5
Other Liabilities, Total 2050 7352 6962 7124 10144 5743
Total Equity 18887 20442 21387 22525 18202 21069
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 1 1 1 1 1 1
Additional Paid-In Capital 454 1264 2282 3051 3880 4661
Retained Earnings (Accumulated Deficit) 18154 19012 19024 19388 14381 16324
Unrealized Gain (Loss) -16 194 -52 1 2 -4
Other Equity, Total 294 -29 132 84 -62 87
Total Liabilities & Shareholders’ Equity 56977 70283 63675 61627 68407 67952
Total Common Shares Outstanding 1307 1308 1282 1266 1254 1254
Other Current Assets, Total 12 73 37
Property/Plant/Equipment, Total - Gross 4289 5197 6592 7281 7556
Accumulated Depreciation, Total -994 -1191 -1422 -1668 -1893
Deferred Income Tax 4356
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 13278 13925 13991 14772 12629
Cash and Short Term Investments 5666 6525 5738 6520 5325
Cash & Equivalents 4065 4893 4362 5338 4296
Short Term Investments 1601 1632 1376 1182 1029
Total Receivables, Net 3925 4149 4566 4493 3787
Accounts Receivable - Trade, Net 3925 4149 4566 4493 3787
Total Inventory 1779 1772 1676 1618 1482
Prepaid Expenses 1908 1479 2011 2141 2035
Total Assets 67492 67984 67098 67952 63080
Property/Plant/Equipment, Total - Net 4990 4996 5037 5121 5253
Goodwill, Net 8334 8334 8332 8332 8314
Intangibles, Net 34781 34341 33900 33455 30331
Long Term Investments 579 836 1099 1309 1427
Other Long Term Assets, Total 5530 5552 4739 4963 5126
Total Current Liabilities 9705 10214 10245 11610 8558
Accounts Payable 570 608 585 705 583
Accrued Expenses 6661 6906 6702 7600 6483
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2259 2261 2511 1516 1025
Other Current Liabilities, Total 215 439 447 1789 467
Total Liabilities 48540 48281 45628 46883 43153
Total Long Term Debt 27907 27914 25175 25179 25183
Long Term Debt 27907 27914 25175 25179 25183
Deferred Income Tax 4464 4374 4603 4356 3687
Minority Interest 12 7 1 -5 -12
Other Liabilities, Total 6452 5772 5604 5743 5737
Total Equity 18952 19703 21470 21069 19927
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 1 1 1 1 1
Additional Paid-In Capital 4092 4271 4492 4661 4867
Retained Earnings (Accumulated Deficit) 14821 15392 16903 16324 14986
Unrealized Gain (Loss) 0 -1 -1 -4 -23
Other Equity, Total 38 40 75 87 96
Total Liabilities & Shareholders’ Equity 67492 67984 67098 67952 63080
Total Common Shares Outstanding 1254 1254 1255 1254 1255
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 13488 4644 5460 5364 89 6201
Cash From Operating Activities 17047 11898 8400 9144 8168 11384
Cash From Operating Activities 177 233 226 255 288 329
Amortization 981 1053 1203 1149 1192 1721
Deferred Taxes -119 -82 289 -2098 -214 -116
Non-Cash Items 974 942 2161 5272 8451 2760
Cash Taxes Paid 2436 3342 3198 1793 2639 2509
Cash Interest Paid 885 1038 1070 982 951 979
Changes in Working Capital 1546 5108 -939 -798 -1638 489
Cash From Investing Activities -11985 -16069 14355 -7817 -14615 -3131
Capital Expenditures -748 -590 -924 -825 -650 -579
Other Investing Cash Flow Items, Total -11237 -15479 15279 -6992 -13965 -2552
Cash From Financing Activities -9725 3393 -12318 -7634 770 -8877
Financing Cash Flow Items -745 -330 -486 -122 -138 -145
Total Cash Dividends Paid -2455 -2731 -2971 -3222 -3449 -3605
Issuance (Retirement) of Stock, Net -10793 -720 -2611 -1540 -1327 -377
Issuance (Retirement) of Debt, Net 4268 7174 -6250 -2750 5684 -4750
Foreign Exchange Effects 41 137 -85 -2 43 -35
Net Change in Cash -4622 -641 10352 -6309 -5634 -659
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1722 3239 5825 6201 12
Cash From Operating Activities 2610 4926 8179 11384 1840
Cash From Operating Activities 78 157 239 329 80
Amortization 395 835 1276 1721 445
Deferred Taxes 71 3 243 -116 -651
Non-Cash Items 753 1564 1921 2760 3116
Changes in Working Capital -409 -872 -1325 489 -1162
Cash From Investing Activities -2042 -2619 -2853 -3131 -1070
Capital Expenditures -165 -284 -423 -579 -247
Other Investing Cash Flow Items, Total -1877 -2335 -2430 -2552 -823
Cash From Financing Activities -2477 -3408 -6935 -8877 -1794
Financing Cash Flow Items -89 -95 -134 -145 -91
Total Cash Dividends Paid -917 -1811 -2711 -3605 -945
Issuance (Retirement) of Stock, Net -221 -252 -340 -377 -258
Issuance (Retirement) of Debt, Net -1250 -1250 -3750 -4750 -500
Foreign Exchange Effects -23 -3 -26 -35 -18
Net Change in Cash -1932 -1104 -1635 -659 -1042
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.9329 111403199 -68465 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 7.025 87609319 3078449 2022-12-31 LOW
Capital World Investors Investment Advisor 5.5242 68892972 11130228 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.7263 58941373 -298977 2022-12-31 LOW
Capital Research Global Investors Investment Advisor 4.3784 54602952 727482 2022-12-31 LOW
Dodge & Cox Investment Advisor/Hedge Fund 2.8775 35885152 -484100 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9123 23848477 244886 2022-12-31 LOW
Invesco Capital Management (QQQ Trust) Investment Advisor 1.3088 16322394 84245 2023-02-28 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.224 15265179 12533445 2022-12-31 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 1.1113 13859234 761084 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0416 12989939 -106202 2022-12-31 LOW
Parnassus Investments, LLC Investment Advisor 0.9672 12062537 295282 2022-12-31 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8569 10686823 -393685 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.7805 9733453 -126327 2022-12-31 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.7772 9693019 -93438 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7531 9391729 -99918 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.7379 9202568 -820000 2022-12-31 HIGH
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.7195 8972729 -116113 2022-12-31 LOW
California Public Employees' Retirement System Pension Fund 0.692 8630001 -344541 2022-12-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.6788 8465274 -377056 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

333 Lakeside Dr
FOSTER CITY
CALIFORNIA 94404-1147
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.39 Price
-1.220% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00314

US100

12,545.80 Price
+0.000% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Gold

1,978.62 Price
-0.040% 1D Chg, %
Biaya inap posisi Long -0.0167%
Biaya inap posisi short 0.0084%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Oil - Crude

66.38 Price
-0.450% 1D Chg, %
Biaya inap posisi Long -0.0200%
Biaya inap posisi short -0.0019%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda